Drugs / FluLaval® Quadrivalent
FluLaval® Quadrivalent
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01974895 | Oct 2013 → Feb 2014 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02242643 | Oct 2014 → Mar 2015 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01440387 | Sep → Oct 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01218308 | Dec 2010 → Jan 2012 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02831751 Comparator | Apr → Jul 2016 | primary viral infectious disease, respiratory tract infectious disorder | Medicago | Completed | No outcome recorded |
| Phase 2 | NCT02768805 Comparator | Mar → May 2016 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03598439 Comparator | Jul 2018 → Mar 2020 | influenza | Marshfield Clinic Research Foundation | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluLaval Quadrivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01218308 ↗ |
| Known as | FluLaval Tetra | “15 µg/strain of the licensed and commercially available quadrivalent vaccine FluLaval® Tetra” NCT02768805 ↗ |
| Known as | Standard IIV4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03598439 ↗ |
| Modality | Vaccine | “candidate inactivated quadrivalent influenza vaccine (QIV)” PMID 24328444 ↗ Dec 2013 |
| Route | Intramuscular | “The vaccine was administered intramuscularly in the deltoid muscle of the non-dominant arm.” NCT01218308 ↗ |